News
Aitua Chief Executive Catherine Beech named in Birthday Honours
13 June 2008
Aitua Limited (“Aitua”), the life science IP commercialisation company, is delighted to announced that its Chief Executive, Dr Catherine Beech has been awarded the OBE for services to innovation and technology in the Queen’s Birthday Honours 2008.
Aitua Ltd Portfolio Company enters into agreement with European medical device company, Vygon
6 February 2008
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Probe Scientific (“Probe”) has entered into an agreement with Vygon, one of Europe’s leading medical device companies and a major supplier to the intensive care market, to co-develop Probe’s revolutionary blood sampling device, MicroEye®, alongside Vygon’s IV access devices.
Aitua Ltd Portfolio Company Innova Establishes Worldwide Distributor Network
13 December 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Innova Biosciences Limited (“Innova”), has just completed its seventh distributor agreement in the last two months.
Probe Scientific strengthens Board with new appointment
6 December 2007
Probe Scientific has strengthened its board by the appointment of George Zajicek as a non executive director.
Aitua Ltd Portfolio Company Probe Scientific Launches its MicroEye® Device and Gains First Export Order
13 November 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that one of its portfolio companies, Probe Scientific (“Probe”), the medical device company, has formally launched its revolutionary MicroEye® device and has already secured its first export order.
BioIndustry Association launches Fledgling Club for early stage bioscience companies
18 October 2007
The BioIndustry Association (BIA) announced at its AGM this week the launch of a Fledgling Club for early stage bioscience companies. To support the Fledgling Club, the BIA is establishing a fledgling company Advisory Committee, chaired by Catherine Beech, Chief Executive of Aitua Ltd.
Aitua invests in ViraBiotech’s instant flu protection
4 October 2007
Aitua Ltd (“Aitua”), the life science IP commercialisation company, today announces that it has invested £50,000 in ViraBiotech Limited (“ViraBiotech”), a company focused on the commercialisation of groundbreaking research by Professor Nigel Dimmock at the University of Warwick which provides a totally new approach to combating flu viruses.
Aitua invests in Lightning-Link™ company Innova
12 June 2007
The life science IP commercialisation company Aitua Limited (“Aitua”) is pleased to announce that it has invested £100,000 into Innova BioSciences Limited (“Innova").
Aitua Ltd Portfolio Company Probe Scientific Gains EU approval for its MicroEye® Device
1 June 2007
Single-use blood sampling device eliminates needle puncture in blood sampling.
Aitua launched on Babraham Research Campus
2 April 2007
Aitua Limited the life science IP commercialisation company was launched today as the new brand for Babraham BioConcepts.
Aitua invests in Specialty Ophthalmic Company Altacor
20 March 2007
Aitua Limited is delighted to announce that it has invested in Altacor Limited, a new specialty pharmaceutical company in the area of therapeutic ophthalmology.
Knowledge Transfer Partnerships 2007 Awards - Keynote Speaker
14 March 2007
Catherine Beech, Chief Executive of Aitua Limited, was a keynote speaker at the Knowledge Transfer Partnerships (KTP) 2007 Awards ceremony in London.
Innova's latest product slashes research processing time
19 February 2007
Innova Biosciences Limited announces the launch of the latest exciting new addition to its revolutionary conjugation technology suite, Lightning-Link™.
CTM Biotech Acquisition to Boost Growth for Alpha Biologics
19 February 2007
Babraham BioConcepts Limited is pleased to announce the sale of portfolio company CTM Biotech to Alpha Biologics Sdn Bdh of Malaysia. The transaction marks BioConcepts’ first exit since its launch in October 2006.
Rainbow Seed Fund backs BioConcepts
18 December 2006
Babraham BioConcepts Limited is today pleased to announce that it has closed additional funding from the Rainbow Seed Fund.
Babraham BioConcepts announces key appointments
6 October 2006
Babraham BioConcepts Limited announced two key appointments to its board; Dr Catherine Beech as Chief Executive and Sir Brian Richards CBE as Non-Executive Chairman.
New pictures of Probe Scientific’s MicroEye™
1 October 2006
These pictures show examples of the first production devices. These have been rigorously tested and meet all the required quality checks.
Launch of Babraham BioConcepts Ltd with £1 million investment by Avlar
BioVentures
5 September 2006
With the injection of £1 million investment from Avlar BioVentures Fund II LLP, Babraham BioConcepts Limited has been launched to form and fund new early-stage life sciences companies associated with the Babraham Research Campus.